1-3 of 3
Stella Maris Ranuncolo, MD/PhD
Close
Sort by
Journal Articles

BCL2 Expression Correlates with Refractory and Relapsed Classic Hodgkin Lymphoma. Its Blokeadge As a Promising Directed-Therapy

Angelica Gamboa-Cedeño, Cristaldo Nancy, MD, Victoria Otero, MD, Natalia Paola Schutz, MDMSc, Dorotea Fantl, MD, Maria Silvana Cugliari, Marta Zerga, MD, Rojas-Bilbao Erica, Hernán García Rivello, Federico Jauk, MD, Myriam Nuñez, PhD, Stella Maris Ranuncolo, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5282.
https://doi.org/10.1182/blood-2019-124452
Published: 2019
Journal Articles

The BCL6 Oncoprotein Forms Distinct Transcriptional Repression Complexes on Cohorts of Target Genes Involved in Specific Cellular Functions.

Jose M. Polo, MS, Stella Maris Ranuncolo, MD/PhD, Samir Parek, MD, Jose Arcaya, Ari M. Melnick, MD
Journal: Blood
Blood (2005) 106 (11): 2615.
https://doi.org/10.1182/blood.V106.11.2615.2615
Published: 2005
Journal Articles

Specific Peptide Disruption of the Bcl-6 Repression Complex Reveals Its Transcriptional Mechanism of Action in Normal and Malignant B-Cells and Is a Novel Therapeutic Approach for Diffuse Large B-Cell Lymphoma.

Jose M. Polo, MS, Tania Dell’Oso, PhD, Stella Maris Ranuncolo, MD, PhD, Leandro Cerchietti, MD, Gustavo F. Da Silva, Pharm.D, Gilvert G. Prive, PhD, Jonathan D. Licht, MD, Ari Melnick, MD
Journal: Blood
Blood (2004) 104 (11): 5.
https://doi.org/10.1182/blood.V104.11.5.5
Published: 2004